(a) An employee or agent of an authorized entity may not provide or administer an epinephrine auto-injector under this subchapter unless he or she completes an anaphylaxis training program. The training program shall be conducted by: (1) A nationally recognized organization experienced in training laypersons in emergency health treatment; or (2) An entity or individual approved by the Department. (b) The training program may be conducted online or in person and shall include instruction on: (1) The recognition of signs and symptoms of severe allergic reactions, including anaphylaxis; (2) Standards and procedures for the storage and administration of an epinephrine auto-injector; and (3) Post-administration emergency medical follow-up procedures. (c) An organization, individual, or entity that conducts the training program shall issue a certificate, on a form developed by the Department, to each person who successfully completes the training program.